Pomalidomide-C8-NH2

Background Introduction

Pomalidomide-C8-NH2 is a specialized E3 ligase ligand-linker conjugate, designed as a key intermediate for the synthesis of PROTACs (Proteolysis Targeting Chimeras) and other targeted protein degradation agents. By incorporating the well-characterized CRBN (cereblon) ligand pomalidomide and a flexible C8 alkyl linker terminating in a primary amine, this compound facilitates modular addition of target protein-binding warheads, streamlining the development of next-generation therapeutics.

Mechanism

Pomalidomide-C8-NH2 functions by acting as a small molecule recruiter of the cereblon (CRBN) E3 ubiquitin ligase complex via its pomalidomide moiety. The attached C8 linker provides optimal spatial separation, and the terminal amine group enables chemical conjugation to diverse target ligands or functional groups. When integrated into a PROTAC construct, this bifunctional molecule brings the E3 ligase and a target protein into proximity, triggering ubiquitination and subsequent proteasomal degradation of the intended protein target.

Applications

Pomalidomide-C8-NH2 is ideal for use in the synthesis and optimization of PROTACs, enabling researchers to selectively degrade pathogenic or otherwise challenging proteins in cellular and in vivo systems. It is widely employed in drug discovery projects for the interrogation of protein function, target validation, and the development of therapeutic degradation agents. The free amine functionality on the C8 linker offers versatile conjugation options for medicinal chemistry, making it a preferred choice for those designing custom PROTACs and targeted protein degradation tools in oncology, neurodegeneration, and immunology research.

The Pomalidomide-C8-NH2 is a versatile E3 Ligase Ligand-Linker Conjugate used in PROTACs for targeted protein degradation. This conjugate offers effective recruitment of E3 ligases, facilitating selective degradation of target proteins. The following provides a detailed description of this molecule, focusing on its linker, ligand, and selection of target protein ligands.

Linker: The linker in Pomalidomide-C8-NH2 is an eight-carbon chain, providing moderate flexibility and sufficient length to bridge the E3 ligase and target protein. It is non-cleavable, ensuring stability and sustained interaction between the conjugated components.

Ligand: The ligand is based on pomalidomide, a well-characterized cereblon-binding molecule. It features a phthalimide ring structure, which is crucial for efficient E3 ligase recruitment and subsequent ubiquitination of the target protein.

Reactive Site: The reactive site is an amine group (-NH2) at the terminal end of the linker, which readily couples with electrophilic warheads on target protein ligands. Recommended reaction types include amide bond formation or reductive amination for stable and efficient conjugation.

Recommended Target Protein Ligand: The molecule is compatible with electrophilic warheads, such as acrylamides or chloroacetamides, which form covalent bonds with cysteine residues. These warheads offer the advantage of irreversible binding, leading to enhanced degradation efficacy. This compatibility makes the conjugate suitable for targeting kinases or other proteins with accessible cysteine residues, enabling precise and efficient protein degradation in research applications.